- Countdown to McKesson ideaShare 2013: MiS to compile best thinking, new ideas for independent pharmacy
- Viva Las Vegas: McKesson ideaShare 2013 electrifies with host of new programs, solutions
- Cardinal Health invites independent pharmacy owners to ‘discover new horizons’ at RBC 2013
- Facing pharmacy trends for the remainder of the year
- Reports: ESI may start 'price war' over new hepatitis C drugs
SAN FRANCISCO — Alternate site pharmacies, including those serving long-term care and correctional care facilities, are realizing significant cost savings and greater efficiencies as a result of an innovative partnership forged by McKesson and Safecor Health, the San Francisco wholesaler announced Monday. According to McKesson, the year-over-year benefit can be as high as 15.5%.
"Alternate site pharmacies manage a great deal of complexity and associated cost in serving their customers, including operational inefficiencies, regulatory mandates, safety concerns and more," stated Rich McKeon, VP McKesson Alternate Site Pharmacy. "The McKesson/Safecor Health Partnership helps to alleviate the cost and complexity burden; it addresses evolving packaging needs based on the pharmacy's business model, without upfront capital investments or extra staff."
The McKesson/Safecor Health Partnership combines McKesson's distribution services with Safecor Health's FDA-registered drug repackaging and barcoding services to deliver customized medication packaging solutions with low pricing to alternate site pharmacies.
The McKesson/Safecor Health Partnership also addresses medication packaging needs for alternate site pharmacies preparing to implement CMS-mandated changes for short-cycle dispensing, which became effective Jan. 1.
McKesson and Safecor Health estimated that a long-term care pharmacy serving 2,000 beds can realize a more than $57,000 annual cost benefit — a 15.5% improvement year over year — as a result of implementing the McKesson/Safecor Health third-party repackaging solution.
Find us on Facebook for more insight, analysis and the latest in drug store news.